Guselkumab

Category: Immunosuppressive



Guselkumab Overview

Guselkumab, sold under the trade name Tremfya, is a monoclonal antibody used to treat plaque psoriasis.[1] Contents 1 Medical uses 2 Adverse effects 3 Pharmacology 3.1 Mechanism of action 3.2 Pharmacokinetics 4 Commercialization 4.1 Cost 4.2 Research and development 5 See also 6 References Medical uses Guselkumab is FDA approved to treat moderate to severe plaque psoriasis in adults.[2] Its use for the treatment of psoriatic arthritis is being ex...

Read more Guselkumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Guselkumab

Recent Guselkumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Guselkumab
  • Injection: 100mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Guselkumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA